W

Withus Pharmaceutical Co Ltd
KOSDAQ:330350

Watchlist Manager
Withus Pharmaceutical Co Ltd
KOSDAQ:330350
Watchlist
Price: 8 850 KRW 2.08% Market Closed
Market Cap: 116.8B KRW

Intrinsic Value

The intrinsic value of one Withus Pharmaceutical Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 8 850 KRW, Withus Pharmaceutical Co Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Withus Pharmaceutical Co Ltd Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Withus Pharmaceutical Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Withus Pharmaceutical Co Ltd looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether Withus Pharmaceutical Co Ltd usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Withus Pharmaceutical Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Withus Pharmaceutical Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Withus Pharmaceutical Co Ltd.

Explain Valuation
Compare Withus Pharmaceutical Co Ltd to

Fundamental Analysis

Withus Pharmaceutical Co Ltd
Company Overview
Loading...
Economic Moat
Loading...
Contacts
Loading...
How do you feel about Withus Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Withus Pharmaceutical Co Ltd

Current Assets 67.6B
Cash & Short-Term Investments 23.1B
Receivables 28B
Other Current Assets 16.5B
Non-Current Assets 70.8B
Long-Term Investments 10.1B
PP&E 48B
Intangibles 11.1B
Other Non-Current Assets 1.5B
Current Liabilities 35.4B
Accounts Payable 11.3B
Accrued Liabilities 611.4m
Short-Term Debt 19B
Other Current Liabilities 4.5B
Non-Current Liabilities 6.9B
Long-Term Debt 1.3B
Other Non-Current Liabilities 5.5B
Efficiency

Free Cash Flow Analysis
Withus Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Withus Pharmaceutical Co Ltd

Revenue
102.5B KRW
Cost of Revenue
-37.4B KRW
Gross Profit
65.1B KRW
Operating Expenses
-59.8B KRW
Operating Income
5.3B KRW
Other Expenses
700.2m KRW
Net Income
6B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

Withus Pharmaceutical Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Gross Margin is Increasing
Declining ROE
hidden
Profitability
Score

Withus Pharmaceutical Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Withus Pharmaceutical Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
High Altman Z-Score
Short-Term Solvency
hidden
Solvency
Score

Withus Pharmaceutical Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Withus Pharmaceutical Co Ltd

There are no price targets for Withus Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Withus Pharmaceutical Co Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Withus Pharmaceutical Co Ltd stock?

The intrinsic value of one Withus Pharmaceutical Co Ltd stock under the Base Case scenario is hidden KRW.

Is Withus Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 8 850 KRW, Withus Pharmaceutical Co Ltd is hidden .

Back to Top